Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 227

1.

A meta-analysis of melanoma risk in industrial workers.

Vujic I, Gandini S, Stanganelli I, Fierro MT, Rappersberger K, Sibilia M, Tosti G, Ferrucci PF, Caini S, De Felici MB, Pagliarello C, Quaglino P, Sanlorenzo M; on behalf of IMI, the Italian Melanoma Intergroup.

Melanoma Res. 2018 Oct 26. doi: 10.1097/CMR.0000000000000531. [Epub ahead of print]

PMID:
30371537
2.

QUALITY OF LIFE IN A RANDOMIZED BREAST CANCER PREVENTION TRIAL OF LOW-DOSE TAMOXIFEN AND FENRETINIDE IN PREMENOPAUSAL WOMEN.

Serrano D, Gandini S, Guerrieri-Gonzaga A, Feroce I, Johansson H, Macis D, Aristarco V, Bonanni B, DeCensi A.

Cancer Prev Res (Phila). 2018 Oct 23. pii: canprevres.0073.2018. doi: 10.1158/1940-6207.CAPR-18-0073. [Epub ahead of print]

PMID:
30352838
3.

Left main coronary wall thickness correlates with the carotid intima media thickness and may provide a new marker of cardiovascular risk.

Ruscica M, Castelnuovo S, Macchi C, Gandini S, Mombelli G, Ferri N, Labombarda F, Sirtori CR.

Eur J Prev Cardiol. 2018 Oct 22:2047487318806985. doi: 10.1177/2047487318806985. [Epub ahead of print] No abstract available.

PMID:
30348004
4.

Stereotactic Body Radiation Therapy for Oligometastatic Ovarian Cancer: A Step Toward a Drug Holiday.

Lazzari R, Ronchi S, Gandini S, Surgo A, Volpe S, Piperno G, Comi S, Pansini F, Fodor C, Orecchia R, Tomao F, Parma G, Colombo N, Jereczek-Fossa BA.

Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):650-660. doi: 10.1016/j.ijrobp.2018.03.058. Epub 2018 Apr 4.

PMID:
29893277
5.

Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors.

Stucci LS, D'Oronzo S, Tucci M, Macerollo A, Ribero S, Spagnolo F, Marra E, Picasso V, Orgiano L, Marconcini R, De Rosa F, Di Guardo L, Galli G, Gandini S, Palmirotta R, Palmieri G, Queirolo P, Silvestris F; Italian Melanoma Intergroup (IMI).

Cancer Treat Rev. 2018 Sep;69:21-28. doi: 10.1016/j.ctrv.2018.05.016. Epub 2018 May 31. Review.

PMID:
29864718
6.

MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project.

Tagliabue E, Gandini S, Bellocco R, Maisonneuve P, Newton-Bishop J, Polsky D, Lazovich D, Kanetsky PA, Ghiorzo P, Gruis NA, Landi MT, Menin C, Fargnoli MC, García-Borrón JC, Han J, Little J, Sera F, Raimondi S.

Cancer Manag Res. 2018 May 14;10:1143-1154. doi: 10.2147/CMAR.S155283. eCollection 2018.

7.

"Give me five" ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach.

Marvaso G, Riva G, Ciardo D, Gandini S, Fodor C, Zerini D, Colangione SP, Timon G, Comi S, Cambria R, Cattani F, De Cobelli O, Orecchia R, Jereczek-Fossa BA.

Med Oncol. 2018 May 10;35(6):96. doi: 10.1007/s12032-018-1155-y.

PMID:
29748830
8.

Sun-Protection Behavior, Pubertal Development and Menarche: Factors Influencing the Melanocytic Nevi Development-The Results of an Observational Study of 1,512 Children.

De Giorgi V, Gori A, Greco A, Savarese I, Alfaioli B, Grazzini M, Rossari S, Papi F, Scarfi F, Janowska A, D'Errico A, Salvati L, Covarelli P, Gandini S.

J Invest Dermatol. 2018 Oct;138(10):2144-2151. doi: 10.1016/j.jid.2018.02.046. Epub 2018 Apr 1.

PMID:
29614272
9.

Fatherhood during dabrafenib and trametinib therapy for metastatic melanoma.

Cocorocchio E, Pala L, Battaglia A, Gandini S, Peccatori FA, Ferrucci PF.

Acta Oncol. 2018 Aug;57(8):1131-1133. doi: 10.1080/0284186X.2018.1449251. Epub 2018 Mar 11. No abstract available.

PMID:
29526130
10.

Axillary web syndrome assessment using a self-assessment questionnaire: a prospective cohort study.

Baggi F, Nevola Teixeira LF, Gandini S, Simoncini MC, Bonacossa E, Sandrin F, Sciotto Marotta M, Lanni G, Dadda P, Colpani D, Luini A.

Support Care Cancer. 2018 Aug;26(8):2801-2807. doi: 10.1007/s00520-018-4123-3. Epub 2018 Mar 5.

PMID:
29508139
11.

Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis.

Gandini S, Palli D, Spadola G, Bendinelli B, Cocorocchio E, Stanganelli I, Miligi L, Masala G, Caini S.

Crit Rev Oncol Hematol. 2018 Feb;122:1-9. doi: 10.1016/j.critrevonc.2017.12.003. Epub 2017 Dec 13. Review.

PMID:
29458778
12.

25-Hydroxyvitamin D serum levels and melanoma risk: a case-control study and evidence synthesis of clinical epidemiological studies.

Cattaruzza MS, Pisani D, Fidanza L, Gandini S, Marmo G, Narcisi A, Bartolazzi A, Carlesimo M.

Eur J Cancer Prev. 2018 Feb 12. doi: 10.1097/CEJ.0000000000000437. [Epub ahead of print]

PMID:
29438161
13.

Alcohol, alcoholic beverages, and melanoma risk: a systematic literature review and dose-response meta-analysis.

Gandini S, Masala G, Palli D, Cavicchi B, Saieva C, Ermini I, Baldini F, Gnagnarella P, Caini S.

Eur J Nutr. 2018 Oct;57(7):2323-2332. doi: 10.1007/s00394-018-1613-5. Epub 2018 Jan 11. Review.

PMID:
29327230
14.

Memories of paternal relations are associated with coping and defense mechanisms in breast cancer patients: an observational study.

Renzi C, Perinel G, Arnaboldi P, Gandini S, Vadilonga V, Rotmensz N, Tagini A, Didier F, Pravettoni G.

BMC Psychol. 2017 Nov 9;5(1):37. doi: 10.1186/s40359-017-0206-z.

15.

Baseline relative eosinophil count as a predictive biomarker for ipilimumab treatment in advanced melanoma.

Ferrucci PF, Gandini S, Cocorocchio E, Pala L, Baldini F, Mosconi M, Antonini Cappellini GC, Albertazzi E, Martinoli C.

Oncotarget. 2017 Aug 1;8(45):79809-79815. doi: 10.18632/oncotarget.19748. eCollection 2017 Oct 3.

16.

Carcinogenicity of High Consumption of Meat and Lung Cancer Risk Among Non-Smokers: A Comprehensive Meta-Analysis.

Gnagnarella P, Caini S, Maisonneuve P, Gandini S.

Nutr Cancer. 2018 Jan;70(1):1-13. doi: 10.1080/01635581.2017.1374420. Epub 2017 Oct 10.

PMID:
29016198
17.

Propranolol for Off-label Treatment of Patients With Melanoma: Results From a Cohort Study.

De Giorgi V, Grazzini M, Benemei S, Marchionni N, Botteri E, Pennacchioli E, Geppetti P, Gandini S.

JAMA Oncol. 2018 Feb 8;4(2):e172908. doi: 10.1001/jamaoncol.2017.2908. Epub 2018 Feb 8.

18.

Clinical benefit and risk of death with endocrine therapy in ovarian cancer: A comprehensive review and meta-analysis.

Paleari L, Gandini S, Provinciali N, Puntoni M, Colombo N, DeCensi A.

Gynecol Oncol. 2017 Sep;146(3):504-513. doi: 10.1016/j.ygyno.2017.06.036. Epub 2017 Jul 10. Review.

19.

Erratum to: Coffee, tea and caffeine intake and the risk of non-melanoma skin cancer: a review of the literature and meta-analysis.

Caini S, Cattaruzza MS, Bendinelli B, Tosti G, Masala G, Gnagnarella P, Assedi M, Stanganelli I, Palli D, Gandini S.

Eur J Nutr. 2017 Aug;56(5):2005. doi: 10.1007/s00394-017-1439-6. No abstract available.

PMID:
28488131
20.

Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression.

Alterio D, Marvaso G, Maffini F, Gandini S, Chiocca S, Ferrari A, Preda L, Rocca MC, Lepanto D, Fodor C, Volpe S, Dicuonzo S, Laudati A, Giugliano G, Ansarin M, Jereczek-Fossa BA.

Med Oncol. 2017 Jun;34(6):107. doi: 10.1007/s12032-017-0965-7. Epub 2017 Apr 27.

PMID:
28452036
21.

A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast Cancer.

Lazzeroni M, Guerrieri-Gonzaga A, Gandini S, Johansson H, Serrano D, Cazzaniga M, Aristarco V, Macis D, Mora S, Caldarella P, Pagani G, Pruneri G, Riva A, Petrangolini G, Morazzoni P, DeCensi A, Bonanni B.

Cancer Prev Res (Phila). 2017 Jun;10(6):363-370. doi: 10.1158/1940-6207.CAPR-16-0298. Epub 2017 Apr 11.

22.

Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab.

Ferrucci PF, Ascierto PA, Pigozzo J, Del Vecchio M, Maio M, Antonini Cappellini GC, Guidoboni M, Queirolo P, Savoia P, Mandalà M, Simeone E, Valpione S, Altomonte M, Spagnolo F, Cocorocchio E, Gandini S, Giannarelli D, Martinoli C.

Ann Oncol. 2018 Feb 1;29(2):524. doi: 10.1093/annonc/mdx059. No abstract available.

PMID:
28379318
23.

β-Blocker use and reduced disease progression in patients with thick melanoma: 8 years of follow-up.

De Giorgi V, Grazzini M, Benemei S, Marchionni N, Geppetti P, Gandini S.

Melanoma Res. 2017 Jun;27(3):268-270. doi: 10.1097/CMR.0000000000000317.

PMID:
28346289
24.

Role of BMI and hormone therapy in melanoma risk: a case-control study.

De Giorgi V, Gori A, Savarese I, D'Errico A, Scarfì F, Papi F, Maio V, Covarelli P, Massi D, Gandini S.

J Cancer Res Clin Oncol. 2017 Jul;143(7):1191-1197. doi: 10.1007/s00432-017-2387-5. Epub 2017 Mar 13.

PMID:
28289899
25.

Effect of soy on metabolic syndrome and cardiovascular risk factors: a randomized controlled trial.

Ruscica M, Pavanello C, Gandini S, Gomaraschi M, Vitali C, Macchi C, Morlotti B, Aiello G, Bosisio R, Calabresi L, Arnoldi A, Sirtori CR, Magni P.

Eur J Nutr. 2018 Mar;57(2):499-511. doi: 10.1007/s00394-016-1333-7. Epub 2016 Oct 18.

26.

Estrogen receptor (ER)β expression and worse outcome from melanoma in pregnant and perimenopausal women.

Gori A, Savarese I, D'Errico A, Grazzini M, Papi F, Maio V, Covarelli P, Massi D, Gandini S, De Giorgi V.

J Am Acad Dermatol. 2016 Sep;75(3):e117. doi: 10.1016/j.jaad.2016.02.1245. No abstract available.

PMID:
27543235
27.

A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen.

Johansson H, Gandini S, Serrano D, Gjerde J, Lattanzi M, Macis D, Guerrieri-Gonzaga A, Aristarco V, Mellgren G, Lien E, DeCensi A, Bonanni B.

Breast Cancer Res Treat. 2016 Aug;159(1):97-108. doi: 10.1007/s10549-016-3932-7. Epub 2016 Aug 2.

PMID:
27484880
28.

Atopic dermatitis, naevi count and skin cancer risk: A meta-analysis.

Gandini S, Stanganelli I, Palli D, De Giorgi V, Masala G, Caini S.

J Dermatol Sci. 2016 Nov;84(2):137-143. doi: 10.1016/j.jdermsci.2016.07.009. Epub 2016 Jul 16.

PMID:
27461758
29.

Coffee, tea and caffeine intake and the risk of non-melanoma skin cancer: a review of the literature and meta-analysis.

Caini S, Cattaruzza MS, Bendinelli B, Tosti G, Masala G, Gnagnarella P, Assedi M, Stanganelli I, Palli D, Gandini S.

Eur J Nutr. 2017 Feb;56(1):1-12. doi: 10.1007/s00394-016-1253-6. Epub 2016 Jul 7. Review. Erratum in: Eur J Nutr. 2017 May 9;:. Cattaruzza, Sofia [corrected to Cattaruzza, Maria Sofia].

PMID:
27388462
30.

Prognostic significance of hematological profiles in melanoma patients.

Gandini S, Ferrucci PF, Botteri E, Tosti G, Barberis M, Pala L, Battaglia A, Clerici A, Spadola G, Cocorocchio E, Martinoli C.

Int J Cancer. 2016 Oct 1;139(7):1618-25. doi: 10.1002/ijc.30215. Epub 2016 Jun 15.

31.

Association of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip Project.

Tagliabue E, Gandini S, García-Borrón JC, Maisonneuve P, Newton-Bishop J, Polsky D, Lazovich D, Kumar R, Ghiorzo P, Ferrucci L, Gruis NA, Puig S, Kanetsky PA, Motokawa T, Ribas G, Landi MT, Fargnoli MC, Wong TH, Stratigos A, Helsing P, Guida G, Autier P, Han J, Little J, Sera F, Raimondi S; M-SKIP Study group.

J Invest Dermatol. 2016 Sep;136(9):1914-7. doi: 10.1016/j.jid.2016.05.099. Epub 2016 May 29. No abstract available.

32.

RE: Prognostic Value of 25-hydroxyvitamin D3 Levels at Diagnosis and During Follow-up in Melanoma Patients.

Raimondi S, Johansson H, Gandini S.

J Natl Cancer Inst. 2016 Apr;108(4). pii: djw014. doi: 10.1093/jnci/djw014. No abstract available.

PMID:
27092382
33.

Sun exposure and melanoma prognostic factors.

Gandini S, Montella M, Ayala F, Benedetto L, Rossi CR, Vecchiato A, Corradin MT, DE Giorgi V, Queirolo P, Zannetti G, Giudice G, Borroni G, Forcignanò R, Peris K, Tosti G, Testori A, Trevisan G, Spagnolo F, Ascierto PA; CLINICAL NATIONAL MELANOMA REGISTRY GROUP.

Oncol Lett. 2016 Apr;11(4):2706-2714. Epub 2016 Mar 1.

34.

Coagulation induced by C3aR-dependent NETosis drives protumorigenic neutrophils during small intestinal tumorigenesis.

Guglietta S, Chiavelli A, Zagato E, Krieg C, Gandini S, Ravenda PS, Bazolli B, Lu B, Penna G, Rescigno M.

Nat Commun. 2016 Mar 21;7:11037. doi: 10.1038/ncomms11037.

35.

Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy.

Caini S, Radice D, Tosti G, Spadola G, Cocorocchio E, Ferrucci PF, Testori A, Pennacchioli E, Fargnoli MC, Palli D, Bazolli B, Botteri E, Gandini S.

J Eur Acad Dermatol Venereol. 2016 Sep;30(9):1491-6. doi: 10.1111/jdv.13645. Epub 2016 Mar 18.

PMID:
26990937
36.

Parental Use and Educational Campaigns on Sunbed Use Among Teenagers and Adolescents.

Stanganelli I, Naldi L, Falcini F, Magi S, Mazzoni L, Medri M, Bertoncini R, Calderoni O, Agnoletti V, Nadiani L, Palmieri G, Di Nuzzo S, Pagliarello C, Gandini S.

Medicine (Baltimore). 2016 Mar;95(11):e3034. doi: 10.1097/MD.0000000000003034.

37.

Dabrafenib in metastatic melanoma: a monocentric 'real life' experience.

Cocorocchio E, Gandini S, Alfieri S, Battaglia A, Pennacchioli E, Tosti G, Spadola G, Barberis M, Leo MD, Riviello C, Pala L, Intelisano A, Martinoli C, Ferrucci PF.

Ecancermedicalscience. 2016 Mar 3;10:624. doi: 10.3332/ecancer.2016.624. eCollection 2016.

38.

Repurposing old drugs to chemoprevention: the case of metformin.

Heckman-Stoddard BM, Gandini S, Puntoni M, Dunn BK, DeCensi A, Szabo E.

Semin Oncol. 2016 Feb;43(1):123-133. doi: 10.1053/j.seminoncol.2015.09.009. Epub 2015 Sep 8. Review.

39.

A Randomized, Placebo-Controlled, Phase II, Presurgical Biomarker Trial of Celecoxib Versus Exemestane in Postmenopausal Breast Cancer Patients.

Aristarco V, Serrano D, Gandini S, Johansson H, Macis D, Guerrieri-Gonzaga A, Lazzeroni M, Feroce I, Pruneri G, Pagani G, Toesca A, Caldarella P, DeCensi A, Bonanni B.

Cancer Prev Res (Phila). 2016 May;9(5):349-56. doi: 10.1158/1940-6207.CAPR-15-0311. Epub 2016 Feb 29.

40.

Incidence and Determinants of Port Occlusions in Cancer Outpatients: A Prospective Cohort Study.

Milani A, Mazzocco K, Gandini S, Pravettoni G, Libutti L, Zencovich C, Sbriglia A, Pari C, Magon G, Saiani L.

Cancer Nurs. 2017 Mar/Apr;40(2):102-107. doi: 10.1097/NCC.0000000000000357.

PMID:
26925994
41.

Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination.

Le CP, Nowell CJ, Kim-Fuchs C, Botteri E, Hiller JG, Ismail H, Pimentel MA, Chai MG, Karnezis T, Rotmensz N, Renne G, Gandini S, Pouton CW, Ferrari D, Möller A, Stacker SA, Sloan EK.

Nat Commun. 2016 Mar 1;7:10634. doi: 10.1038/ncomms10634.

42.

Food of animal origin and risk of non-Hodgkin lymphoma and multiple myeloma: A review of the literature and meta-analysis.

Caini S, Masala G, Gnagnarella P, Ermini I, Russell-Edu W, Palli D, Gandini S.

Crit Rev Oncol Hematol. 2016 Apr;100:16-24. doi: 10.1016/j.critrevonc.2016.02.011. Epub 2016 Feb 18. Review.

PMID:
26921971
43.

Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis.

Raimondi S, Botteri E, Munzone E, Cipolla C, Rotmensz N, DeCensi A, Gandini S.

Int J Cancer. 2016 Jul 1;139(1):212-9. doi: 10.1002/ijc.30062. Epub 2016 Mar 12.

44.

Stress Exposure in Significant Relationships Is Associated with Lymph Node Status in Breast Cancer.

Renzi C, Vadilonga V, Gandini S, Perinel G, Rotmensz N, Didier F, Rescigno M, Pravettoni G.

PLoS One. 2016 Feb 24;11(2):e0149443. doi: 10.1371/journal.pone.0149443. eCollection 2016.

45.

PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis.

Gandini S, Massi D, Mandalà M.

Crit Rev Oncol Hematol. 2016 Apr;100:88-98. doi: 10.1016/j.critrevonc.2016.02.001. Epub 2016 Feb 10. Review.

PMID:
26895815
46.

Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab.

Ferrucci PF, Ascierto PA, Pigozzo J, Del Vecchio M, Maio M, Antonini Cappellini GC, Guidoboni M, Queirolo P, Savoia P, Mandalà M, Simeone E, Valpione S, Altomonte M, Spagnolo F, Cocorocchio E, Gandini S, Giannarelli D, Martinoli C.

Ann Oncol. 2016 Apr;27(4):732-8. doi: 10.1093/annonc/mdw016. Epub 2016 Jan 22.

PMID:
26802161
47.

A Presurgical Study of Oral Silybin-Phosphatidylcholine in Patients with Early Breast Cancer.

Lazzeroni M, Guerrieri-Gonzaga A, Gandini S, Johansson H, Serrano D, Cazzaniga M, Aristarco V, Puccio A, Mora S, Caldarella P, Pagani G, Pruneri G, Riva A, Petrangolini G, Morazzoni P, DeCensi A, Bonanni B.

Cancer Prev Res (Phila). 2016 Jan;9(1):89-95. doi: 10.1158/1940-6207.CAPR-15-0123. Epub 2015 Nov 2.

48.

Melanoma mortality following skin cancer screening in Germany.

Boniol M, Autier P, Gandini S.

BMJ Open. 2015 Sep 15;5(9):e008158. doi: 10.1136/bmjopen-2015-008158.

49.

Meta-analysis of vitamin D-binding protein and cancer risk.

Tagliabue E, Raimondi S, Gandini S.

Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1758-65. doi: 10.1158/1055-9965.EPI-15-0262. Epub 2015 Sep 12.

50.

Telomere length and the risk of cutaneous melanoma and non-melanoma skin cancer: a review of the literature and meta-analysis.

Caini S, Raimondi S, Johansson H, De Giorgi V, Zanna I, Palli D, Gandini S.

J Dermatol Sci. 2015 Dec;80(3):168-74. doi: 10.1016/j.jdermsci.2015.08.003. Epub 2015 Aug 22. Review.

PMID:
26341697

Supplemental Content

Loading ...
Support Center